Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 85-2306010

EPIDEMIOLOGIC SOLUTIONS CORPORATION

Tax-exempt · WESTLAKE, LA 70669

Financials

$22K$469K2023$4.7M$1.8M2024
Revenue Expenses · by fiscal year end
Financials of EPIDEMIOLOGIC SOLUTIONS CORPORATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$4,663,007$1,779,017$2,883,990$3,434,152$0$3,434,152
December 31, 2023990$22,234$469,188-$446,954$574,186$24,025$550,161
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$356,736
Program service revenue
$0
Investment income
$0
Other revenue
$4,306,271

Expenses

Grants and similar amounts paid
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Program services (functional)
$1,739,349
Management and general (functional)
$39,668

Balance sheet and other

Total assets, start of year
$574,186
Total assets, end of year
$3,434,152
Total liabilities, end of year
$0
Net assets, end of year
$3,434,152
Publicly traded securities
$3,424,129
Gross receipts
$4,663,007
Employees
0
Year formed
2020
State of legal domicile
LA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
RONNIE GODEAUXCEO
Trustee or director
0$0
990 for the year ended December 31, 2023: 1 people
NameTitleHours / weekCompensation
RONNIE GODEAUXCEO
Trustee or director, Officer
0$0

Address and contacts

Address (IRS master file)
401 DALTON RD, WESTLAKE, LA 70669-6367
In care of
% RONNIE GODEAUX
Principal officer (990 for 2024)
RONNIE GODEAUX, 401 DALTON ROAD, Westlake, LA 70669
Signed the 990
RONNIE GODEAUX, CEO
Phone
(337) 794-6402
Return prepared by
PROGRESSIVE FINANCIAL CONSULTATION

Mission

MOST SIGNIFICANTLY, RESEARCH TO DEVELOP TREATMENTS FOR A RANGE OF DISEASES, PRINCIPALLY FOCUSED ON EXTRACORPOREAL METHOD TREATS. BLOOD-BORNE,NEUROLOGIC AND INFECTIOUS DISEASES, BY REMOVING BODILY FLUIDS IN A CONTINUOUS FASHION LIKE DIALYSIS, OR IN A BATCH PROCESS.

990 for the year ended December 31, 2024

Program accomplishments

  • MOST SIGNIFICANTLY, RESEARCH TO DEVELOP TREATMENTS FOR A RANGE OF DISEASES, PRINCIPALLY FOCUSED ON EXTRACORPOREAL METHOD TREATS BLOOD-BORNE, NEUROLOGIC AND INFECTIOUS DISEASES, BY REMOVING BODILY FLUIDS IN A CONTINUOUS FASHION, LIKE DIALYSIS, OR IN A BATCH PROCESS. TO TREAT THE SPECIFIC DISEASE, THE TREATMENT IS APPLIED TO THE BODILY FLUID. DISEASE ERADICATION VIA EXPOSURE TO RADIO FREQUENCY, LASER IRRADIATION, OR CHEMICAL BONDING.
    Expenses $1,739,349

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
85-2306010
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2020
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H80)
Assets (IRS master file)
$3,434,152
Income (IRS master file)
$4,663,007

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$4,663,007$1,779,017$3,434,152IRS
990December 2023$22,234$469,188$574,186XML
990December 2022$940,634$336,927$997,115IRS
990December 2021-$499,806$0$393,408IRS
990December 2020$893,214$0$893,214IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 85-2306010).

Questions about EPIDEMIOLOGIC SOLUTIONS CORPORATION

What is the EIN of EPIDEMIOLOGIC SOLUTIONS CORPORATION?
The employer identification number (EIN) of EPIDEMIOLOGIC SOLUTIONS CORPORATION is 85-2306010.
Is EPIDEMIOLOGIC SOLUTIONS CORPORATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2020.
Are donations to EPIDEMIOLOGIC SOLUTIONS CORPORATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does EPIDEMIOLOGIC SOLUTIONS CORPORATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of EPIDEMIOLOGIC SOLUTIONS CORPORATION due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did EPIDEMIOLOGIC SOLUTIONS CORPORATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of EPIDEMIOLOGIC SOLUTIONS CORPORATION?
The 990 for the year ended December 31, 2024 names RONNIE GODEAUX.
Who are the officers and directors of EPIDEMIOLOGIC SOLUTIONS CORPORATION?
The 990 for the year ended December 31, 2024 lists 1 person; 0 received compensation from the organization.
How much revenue does EPIDEMIOLOGIC SOLUTIONS CORPORATION have?
On its 990 for the year ended December 31, 2024 it reported revenue of $4,663,007, expenses of $1,779,017 and total assets of $3,434,152 at year end.

Other nonprofits in WESTLAKE

All nonprofits in WESTLAKE · Louisiana · Medical research